Association between the Human Development Index and the burden of major gastrointestinal cancers: results from Global Burden of Disease 2021.
1/5 보강
[AIM] To assess the longitudinal association between the Human Development Index (HDI) and the global burden of major gastrointestinal (GI) cancers from 1990 to 2021.
APA
Azizmohammad Looha M, Saberi Shahrbabaki A, et al. (2025). Association between the Human Development Index and the burden of major gastrointestinal cancers: results from Global Burden of Disease 2021.. Gastroenterology and hepatology from bed to bench, 18(4), 467-482. https://doi.org/10.22037/ghfbb.v18i4.3203
MLA
Azizmohammad Looha M, et al.. "Association between the Human Development Index and the burden of major gastrointestinal cancers: results from Global Burden of Disease 2021.." Gastroenterology and hepatology from bed to bench, vol. 18, no. 4, 2025, pp. 467-482.
PMID
41777922 ↗
Abstract 한글 요약
[AIM] To assess the longitudinal association between the Human Development Index (HDI) and the global burden of major gastrointestinal (GI) cancers from 1990 to 2021.
[BACKGROUND] GI cancers contribute substantially to global incidence, mortality, and disability-adjusted life years (DALYs), with wide variation across HDI levels.
[METHODS] Using Global Burden of Disease 2021 data, we analyzed age-standardized incidence (ASIR), mortality (ASMR), disability-adjusted life-year (ASDR), and tobacco-attributable mortality for colorectal, liver, pancreatic, and stomach cancers (1990-2021). Countries were classified as more developed (HDI ≥0.700) or less developed (HDI <0.700), and associations were assessed using longitudinal multilevel mixed-effects models and Spearman correlations.
[RESULTS] In 2021, HDI was positively correlated with colorectal and pancreatic cancer burden, while liver cancer showed inverse associations only in less developed countries and stomach cancer only in more developed settings. For tobacco-attributable ASMR, associations were positive for colorectal and pancreatic cancers, non-significant for liver, and opposite for stomach (positive in less vs. inverse in more developed countries). Longitudinally (1990-2021), colorectal cancer showed a rising ASIR in both groups, but significantly divergent slopes for ASMR and ASDR, with declining rates in more developed countries and increasing rates in less developed countries. Liver cancer had significantly unfavorable slopes, with ASIR, ASMR, and ASDR increasing in more developed but declining in less developed settings. Pancreatic cancer exhibited increases in all measures, with significantly slower growth in more developed countries. Stomach cancer showed consistent declines across all measures, with considerably steeper reductions in more developed regions.
[CONCLUSION] Human development strongly shapes GI cancer burden, with divergent high- and low-HDI trends evident only in longitudinal analyses.
[BACKGROUND] GI cancers contribute substantially to global incidence, mortality, and disability-adjusted life years (DALYs), with wide variation across HDI levels.
[METHODS] Using Global Burden of Disease 2021 data, we analyzed age-standardized incidence (ASIR), mortality (ASMR), disability-adjusted life-year (ASDR), and tobacco-attributable mortality for colorectal, liver, pancreatic, and stomach cancers (1990-2021). Countries were classified as more developed (HDI ≥0.700) or less developed (HDI <0.700), and associations were assessed using longitudinal multilevel mixed-effects models and Spearman correlations.
[RESULTS] In 2021, HDI was positively correlated with colorectal and pancreatic cancer burden, while liver cancer showed inverse associations only in less developed countries and stomach cancer only in more developed settings. For tobacco-attributable ASMR, associations were positive for colorectal and pancreatic cancers, non-significant for liver, and opposite for stomach (positive in less vs. inverse in more developed countries). Longitudinally (1990-2021), colorectal cancer showed a rising ASIR in both groups, but significantly divergent slopes for ASMR and ASDR, with declining rates in more developed countries and increasing rates in less developed countries. Liver cancer had significantly unfavorable slopes, with ASIR, ASMR, and ASDR increasing in more developed but declining in less developed settings. Pancreatic cancer exhibited increases in all measures, with significantly slower growth in more developed countries. Stomach cancer showed consistent declines across all measures, with considerably steeper reductions in more developed regions.
[CONCLUSION] Human development strongly shapes GI cancer burden, with divergent high- and low-HDI trends evident only in longitudinal analyses.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Obesity-driven thyroid cancer burden in middle-aged and older populations: temporal trends and projected trajectories based on the Global Burden of Disease study.
- Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study.
- Impact of Human Development Index Category on Prostate Cancer Characteristics in Asia.
- Global and National Burden of Chronic Obstructive Pulmonary Disease and Tracheal, Bronchus, and Lung Cancer From 1990 to 2021: Comorbidity Burden Analysis Based on the Global Burden of Disease Study 2021.
- Polymorphisms of long non-coding RNA HOTAIR and susceptibility to gastrointestinal cancers: A meta-analysis.
- Burden of Middle-Aged and Elderly Patients With Non-Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021.